Persistent URL of this record https://hdl.handle.net/1887/97318
In Collections
This item can be found in the following collections:
First in Patient Study of Anti-GM-CSF Monoclonal Antibody (MOR103) in Active Rheumatoid Arthritis: Results of a Phase 1b/2a Randomized, Double-Blind, Placebo-Controlled Trial
- All authors
- Behrens, F.; Ostergaard, M.; Stoilov, R.; Wiland, P.; Huizinga, T.W.; Berenfus, V.Y.; Tak, P.P.; Vladeva, S.; Rech, J.; Rubbert-Roth, A.; Korkosz, M.; Rekalov, D.; Zupanets, I.A.; Ejbjerg, B.J.; Geiseler, J.; Fresenius, J.; Korolkiewicz, R.P.; Schottelius, A.J.; Burkhardt, H.
- Date
- 2012-12-31
- Journal
- Arthritis and Rheumatism
- Volume
- 64
- Issue
- 12
- Pages
- 4171 - 4172